Dr. Phillip Low is a Neurologist at the Mayo Clinic focusing on Autonomic Disorders. Phillip A. Low, M.D. has a long-standing research focus on clinical and laboratory research into the cause and treatment of autonomic disorders. Efforts have been concentrated on following major areas: multiple system atrophy; development of novel biomarkers and tests and instruments to study autonomic disorders; diagnosis and treatment of autonomic neuropathies; conducting randomized clinical trials. Dr. Low's research has been continuously funded by the National Institutes of Health (NIH) for over the past 30 years.

• Part I. Anatomy; Part II. Pharmacology; Part III. Physiology; Part IV. Stress; Part V. Neuropathology; Part VI. Evaluation of Autonomic Function; Part VII. Cardiovascular Disorders; Part VIII. Catecholamine Disorders; Part IX. Central Autonomic Disorders; Part X. Peripheral Autonomic Failure; Part XI. Orthostatic Intolerance; Part XII. Other Clinical Conditions; Part XIII. Management of Autonomic Disorders; Part XIV. Experimental Autonomic Neuroscience.

Dr. Phillip Low is a Neurologist at the Mayo Clinic focusing on Autonomic Disorders. Phillip A. Low, M.D. has a long-standing research focus on clinical and laboratory research into the cause and treatment of autonomic disorders. Efforts have been concentrated on following major areas: multiple system atrophy; development of novel biomarkers and tests and instruments to study autonomic disorders; diagnosis and treatment of autonomic neuropathies; conducting randomized clinical trials. Dr. Low's research has been continuously funded by the National Institutes of Health (NIH) for over the past 30 years.

• Part I. Anatomy; Part II. Pharmacology; Part III. Physiology; Part IV. Stress; Part V. Neuropathology; Part VI. Evaluation of Autonomic Function; Part VII. Cardiovascular Disorders; Part VIII. Catecholamine Disorders; Part IX. Central Autonomic Disorders; Part X. Peripheral Autonomic Failure; Part XI. Orthostatic Intolerance; Part XII. Other Clinical Conditions; Part XIII. Management of Autonomic Disorders; Part XIV. Experimental Autonomic Neuroscience.